Arginase and C-reactive Protein As Potential Serum-based Biomarker of Head and Neck Squamous Cell Carcinoma Patients of North East India

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2014 Apr 10

PMID 24715304

Citations 4

Authors

Biswadeep Choudhury

Shilpee Srivastava

Haider H Choudhury

Alokananda Purkayastha

Sumita DuttaGupta

Sankar Kumar Ghosh

Affiliations

Soon will be listed here.

Abstract

Head and neck squamous cell carcinoma (HNSCC) diagnosis involves histopathological investigations with intervention procedures. Widely accepted biochemical panels for HNSCC detection is not available yet. We tried to find out the effectiveness of the serum-based biochemical markers for their prognostic significance in HNSCC. We collected fresh blood samples of 80 HNSCC patients and 100 healthy subjects. Samples were analyzed for absolute levels of arginase (ARG), ornithine aminotransferase (OAT), catalase (CAT), lactate dehydrogenase (LDH), amylase (AMY) activity, and C-reactive protein (CRP). Receiver-operator characteristic curves and Fagan's nomograms were generated. Out of six parameters studied, four (OAT, CAT, LDH, and AMY) did not show biologically significant differences to be used as biomarkers. Significant elevation in serum ARG and CRP levels were observed in HNSCC. The individual estimation of ARG and CRP showed lower specificity, but their combination improved the specificity level to 95%. Our results suggest that serum ARG and CRP together can efficiently diagnose HNSCC.

Citing Articles

Arginase-1 in Plasma-Derived Exosomes as Marker of Metastasis in Patients with Head and Neck Squamous Cell Carcinoma.

Hofmann L, Harasymczuk M, Huber D, Szczepanski M, Dworacki G, Whiteside T Cancers (Basel). 2023; 15(22).

PMID: 38001706 PMC: 10670520. DOI: 10.3390/cancers15225449.

Association of Head and Neck Cancers in Chronic Osteomyelitis: A National Retrospective Cohort Study.

Tsai C, Ho M, Lin D, Chen H, Muo C, Tseng C Medicine (Baltimore). 2016; 95(3):e2407.

PMID: 26817870 PMC: 4998244. DOI: 10.1097/MD.0000000000002407.

The immunobiology of myeloid-derived suppressor cells in cancer.

Motallebnezhad M, Jadidi-Niaragh F, Safaie Qamsari E, Bagheri S, Gharibi T, Yousefi M Tumour Biol. 2015; 37(2):1387-406.

PMID: 26611648 DOI: 10.1007/s13277-015-4477-9.

Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.

Choudhury J, Singh S, Kundu S, Choudhury B, Talukdar F, Srivasta S Tumour Biol. 2015; 36(8):5773-83.

PMID: 25724184 DOI: 10.1007/s13277-015-3246-0.

References

Glorieux C, Dejeans N, Sid B, Beck R, Buc Calderon P, Verrax J . Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol. 2011; 82(10):1384-90. DOI: 10.1016/j.bcp.2011.06.007. View

Mumenthaler S, Yu H, Tze S, Cederbaum S, Pegg A, Seligson D . Expression of arginase II in prostate cancer. Int J Oncol. 2008; 32(2):357-65. View

Kruse A, Luebbers H, Gratz K . C-reactive protein levels: a prognostic marker for patients with head and neck cancer?. Head Neck Oncol. 2010; 2:21. PMC: 2921363. DOI: 10.1186/1758-3284-2-21. View

Perez G, Olivares I, Rodriguez M, Ceballos G, Garcia Sanchez J . Arginase activity in patients with breast cancer: an analysis of plasma, tumors, and its relationship with the presence of the estrogen receptor. Onkologie. 2012; 35(10):570-4. DOI: 10.1159/000343005. View

Prizment A, Folsom A, Dreyfus J, Anderson K, Visvanathan K, Joshu C . Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study. Cancer Causes Control. 2013; 24(12):2077-87. PMC: 3836434. DOI: 10.1007/s10552-013-0285-y. View

Sullivan N, Tober K, Burns E, Schick J, Riggenbach J, Mace T . UV light B-mediated inhibition of skin catalase activity promotes Gr-1+ CD11b+ myeloid cell expansion. J Invest Dermatol. 2011; 132(3 Pt 1):695-702. PMC: 3270125. DOI: 10.1038/jid.2011.329. View

Armstrong A, George D, Halabi S . Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin. J Clin Oncol. 2012; 30(27):3402-7. DOI: 10.1200/JCO.2011.40.9631. View

Nozoe T, Saeki H, Ohga T, Sugimachi K . Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence. Dis Esophagus. 2002; 15(2):145-8. DOI: 10.1046/j.1442-2050.2002.00241.x. View

Wang F, Arun P, Friedman J, Chen Z, Van Waes C . Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol. 2009; 9(4):389-95. PMC: 2731001. DOI: 10.1016/j.coph.2009.06.005. View

10.

Crumley A, McMillan D, McKernan M, Going J, Shearer C, Stuart R . An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer. 2006; 94(11):1568-71. PMC: 2361311. DOI: 10.1038/sj.bjc.6603150. View

11.

Shi D, Xie F, Zhai C, Stern J, Liu Y, Liu S . The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol Cancer. 2009; 8:32. PMC: 2702299. DOI: 10.1186/1476-4598-8-32. View

12.

Horder M, Gerhardt W . The Scandinavian Committee on Enzymes (SCE). Scand J Clin Lab Invest Suppl. 1985; 179:13-7. View

13.

Allin K, Bojesen S, Nordestgaard B . Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009; 27(13):2217-24. DOI: 10.1200/JCO.2008.19.8440. View

14.

Feun L, You M, Wu C, Kuo M, Wangpaichitr M, Spector S . Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 2008; 14(11):1049-57. PMC: 3096551. DOI: 10.2174/138161208784246199. View

15.

Feron O . Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol. 2009; 92(3):329-33. DOI: 10.1016/j.radonc.2009.06.025. View

16.

CHEN I, KEREIAKES J, Silberstein E, ARON B, SAENGER E . Radiation-induced change in serum and urinary amylase levels in man. Radiat Res. 1973; 54(1):141-51. View

17.

Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T . Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci. 2014; 105(4):409-17. PMC: 4317800. DOI: 10.1111/cas.12369. View

18.

Takeuchi T, Fujiki H, Kameya T . Characterization of amylases produced by tumors. Clin Chem. 1981; 27(4):556-9. View

19.

Goh J, Enns L, Fatemie S, Hopkins H, Morton J, Pettan-Brewer C . Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer. 2011; 11:191. PMC: 3123323. DOI: 10.1186/1471-2407-11-191. View

20.

Parkin D, Pisani P, Ferlay J . Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993; 54(4):594-606. DOI: 10.1002/ijc.2910540413. View